ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 1 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $27 | -100.0% | 14,626 | -97.5% | 0.00% | -100.0% |
Q3 2022 | $99,000 | -37.3% | 585,000 | 0.0% | 0.00% | -50.0% |
Q2 2022 | $158,000 | -51.8% | 585,000 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $328,000 | -20.6% | 585,000 | 0.0% | 0.00% | -25.0% |
Q4 2021 | $413,000 | -56.7% | 585,000 | 0.0% | 0.00% | -63.6% |
Q3 2021 | $954,000 | -18.0% | 585,000 | 0.0% | 0.01% | -15.4% |
Q2 2021 | $1,164,000 | -40.1% | 585,000 | 0.0% | 0.01% | -40.9% |
Q1 2021 | $1,942,000 | -10.7% | 585,000 | 0.0% | 0.02% | -26.7% |
Q4 2020 | $2,175,000 | +41.3% | 585,000 | 0.0% | 0.03% | +15.4% |
Q3 2020 | $1,539,000 | -13.2% | 585,000 | 0.0% | 0.03% | -25.7% |
Q2 2020 | $1,773,000 | +54.6% | 585,000 | 0.0% | 0.04% | +20.7% |
Q1 2020 | $1,147,000 | -99.8% | 585,000 | +13485.7% | 0.03% | -95.4% |
Q4 2019 | $585,000,000 | +22025.6% | 4,306 | -99.3% | 0.63% | +881.2% |
Q3 2019 | $2,644,000 | -55.4% | 585,000 | -1.7% | 0.06% | -52.9% |
Q2 2019 | $5,932,000 | – | 595,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,930,092 | $1,363,000 | 0.55% |
AMERICAN FINANCIAL GROUP INC | 1,480,000 | $1,045,000 | 0.29% |
Vanguard Capital Wealth Advisors | 158,900 | $111,000 | 0.08% |
Anson Funds Management LP | 553,652 | $391,000 | 0.04% |
Nantahala Capital Management | 894,659 | $632,000 | 0.02% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,479,000 | 0.02% |
Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $831,000 | 0.02% |
Atom Investors LP | 113,151 | $80,000 | 0.01% |
Virtu Financial LLC | 130,270 | $91,000 | 0.01% |
Altshuler Shaham Ltd | 1,157,540 | $828,000 | 0.01% |